Ming Wang, MD, PhD is a clinical associate professor of ophthalmology of the University of Tennessee, co-owner and international president of Shanghai Aier Eye Hospital, attending surgeon at Saint Thomas Hospital, and director of Wang Vision Institute in Nashville, Tennessee. Dr. Wang received his BS from the University of Science and Technology of China in Hefei, China; his PhD in laser spectroscopy and atomic collision dynamics from the University of Maryland in College Park, Maryland; his postdoctoral fellowship at the Massachusetts Institute of Technology in Boston, Massachusetts; and his MD from Harvard Medical School and MIT in Boston, Massachusetts. He graduated magna cum laude, received the best graduation thesis award, and the Harold Lamport Biomedical Research Prize from Harvard and MIT. After completing both a residency in ophthalmology and a fellowship in ocular genetics and molecular biology at the Wills Eye Hospital in Philadelphia, Pennsylvania, he completed a clinical fellowship in cornea, external disease and refractive surgery from the Bascom Palmer Eye Institute at the University of Miami School of Medicine in Miami, Florida. In 1997, he became the founding director of the Vanderbilt Laser Sight Center and a full-time faculty member of the Department of Ophthalmology at the Vanderbilt University School of Medicine in Nashville, Tennessee. He remained there until 2002, when he went into private practice and established the Wang Vision Institute and Wang Foundation for Sight Restoration. Dr. Wang started his research career as a laser physicist and physical chemist. From 1982 to 1987, as its first author, he published a dozen original papers in the leading physics journal, Physical Review A, describing the development of a novel experimental atomic physics technique that he developed with Professor John Weiner, a Doppler velocity-selected associative ionization process between sodium atoms. In 1987, Dr. Wang enrolled in Harvard Medical School and MIT, where he conducted molecular biology research and published a paper in the world-renowned journal Nature, in which he described a novel molecular biology technique--a whole-genome approach to in vivo DAN-protein interaction and gene-expression regulation--that he invented with Professor George Church. In 1991, after completing his MD, he began research in the field of ophthalmology, specifically ophthalmic genetics and corneal wound healing, at Wills Eye Hospital and Bascom Palmer Eye Institute. Dr. Wang made an original contribution to the field of corneal wound healing by co-publishing with Professor Scheffer Tseng the first paper of its kind regarding laboratory success of the reduction of corneal scarring and keratocyte apoptosis with amniotic membrane transplantation. Dr. Wang is an inventor of several US patented technologies, including an amniotic membrane contact lens, of which he successfully created the first prototype. He was a former panel consultant of the United States Food and Drug Administration (FDA) Ophthalmic Device Panel, and was a primary FDA reviewer for the first US FDA LASIK PMA approval in 1999. Dr. Wang conducted the first large-scale clinical study and was the principal investigator of the first three-dimensional stereo corneal topographer, the AstraMax. He was the first surgeon from the United States to study a new, high frequency excimer laser and treatment platform designed to treat post-LASIK complications. Dr. Wang performed the first femtosecond laser-assisted artificial cornea implantation. He was also a LASIK surgeon for ABC's national reality TV show, Extreme Makeover. Dr. Wang received an honored award from the American Academy of Ophthalmology in 2003. He was a co-principal investigator of an NIH RO1 grant, a recipient of Fight For Sight Grant-in-aid, Lawrence Award of the Association for Research in Vision and Ophthalmology (ARVO), and Faculty Investigator Award of Vanderbilt University. He has edited several books, including Corneal Dystrophy and Degenerations-A Molecular Biology Approach, Corneal Topography in the Wavefront Era (SLACK Incorporated, 2006), and Irregular Astigmatism: Diagnosis and Treatment (SLACK Incorporated, 2007). Dr. Wang is a reviewer of many journals including: Ophthalmology, American Journal of Ophthalmology, Cornea, Journal of Cataract and Refractive Surgery, Journal of Refractive Surgery, Genome, and Investigative Ophthalmology and Visual Sciences. Dr. Wang introduced femtosecond-laser LASIK to China and performed the first all-laser LASIK in China in 2005. He is a co-owner and medical director of refractive surgery of Aier Eye Hospitals, the largest private eye hospital group in China, which holds 10% of China's refractive surgery volume, with the majority of its medical equipment made in the USA. In 2007, Dr. Wang founded the first Chinese chamber of commerce of the state of Tennessee, the Tennessee Chinese Chamber of Commerce, and contributed to the effort that helped Tennessee to become number one in the United States in the growth rate of export to China. In 2003, Dr. Wang founded a non-profit 501c(3) charity, the Wang Foundation for Sight Restoration, which assists severely corneally injured patients in undergoing novel eye reconstructive surgeries that are performed free of charge by Dr. Wang. Each year the foundation holds its major fund-raising gala, the EyeBall. To date, the foundation has helped patients from over 40 states in the US and 55 countries worldwide. Dr. Wang has diverse interests and hobbies. He is a reigning finalist in the world ballroom dance championships in open pro-am international 10-dance, and was a former member of the US collegiate champion Harvard University ballroom dance team. Dr. Wang performs with a Chinese violin (er-hu), and played it with country music legend Dolly Parton on a song, "The Cruel War," from her recent CD, Those Were The Days. Dr. Wang lives in Nashville, Tennessee with his beautiful wife and artist Ye-jia "JJ" Wang. Tracy Schroeder Swartz, OD, MS, FAAO currently serves as the Center Director of VisionAmerica in Hunstville, Alabama, where she practices consultative optometry, specializing in ocular surface disease and dry eye. Originally from Wisconsin, Dr. Swartz attended Indiana University School of Optometry, graduating in 1994. After completing her doctorate, she pursued a master's degree in Physiological Optics, specializing in pediatrics. She served as faculty at the IU School of Optometry for 4 years, and earned the Indiana Chapter of the American Academy of Optometry Gordon Heath Fellowship, 1996. After completion of her master's, she relocated to Metro DC, where she specialized in comanagement of refractive and corneal surgery. She later joined Wang Vision Institute in Nashville, Tennessee, where she served as Director of Clinical Operations, Residency Director for the Optometric Residency Program, and adjunct faculty to Indiana University School of Optometry. While there, she edited two textbooks with Ming Wang, MD, PhD: Corneal Topography in the Wavefront Era and Irregular Astigmatism: Diagnosis and Treatment (both for SLACK Incorporated), as well as authoring numerous book chapters on refractive surgery, topography, aberrometry, and anterior segment disease. She served as co-editor for the literature review column for Cataract and Refractive Surgery Today from 2003 to 2008, and currently serves on the editorial board of Optometry Times. She is adjunct faculty for the School of Optometry at the University of Waterloo, and serves on the board of the Optometric Council of Refractive Technology.
More books by Ming Wang